Monoclonal antibody drugs have emerged as powerful tools in the fight against cancer, revolutionising treatment approaches.
Monoclonal Antibody Drugs for Cancer
Insights into the Molecular Mechanisms Regulating Necroptosis
This white paper details findings in molecular mechanisms that govern necroptosis related to RIPK & details #2283 use to analyse expression of RIPK3.
Exploring the Roles of RIPKs in Immune Responses, Inflammation, and Cell Death: Recent Findings
ProSci has 25+ years expertise in developing antibodies. This white paper details use of RIPK antibodies & findings on RIPKs in signalling pathways.
A Deep Dive into the Hidden Power of Programmed Cell Death: Unlocking Therapeutic Potential with Antibodies
ProSci has 25+ years of expertise in developing antibodies. This white paper details use of ProSci antibodies in the study of programmed cell death.
PD-1: Expanding Beyond Cancer Research
ProSci details the importance of PD-1 antibodies are important in resolving complex interactions between the immune system & pathological conditions.
Leveraging Anti-Integrin αvβ6 Antibodies for Ulcerative Colitis
MBLI is proud to introduce the Anti-Integrin αvβ6 ELISA Kit that readily allows measurement of anti-integrin αvβ6 antibody levels in human serum.
Poly(ADP-ribosyl)ation (PARylation) – An Important Posttranslational Modification
AdipoGen Life Sciences provide high quality reagents for PAR & PARP research
PANoptosis – Inflammatory Cell Death
PANoptosomes are involved in many diseases including autoinflammatory, metabolic & neurodegenerative diseases, cancer & microbial human infections.
Non-Animal Source Multiclonal Recombinant Secondary Antibodies
MULTICLONALS are recombinant secondary antibodies developed by AdipoGen’s innovative partner Abcalis.
Neutralising Antibody Detection Kits for SARS-CoV-2 Variants
List of AdipoGen Life Sciences’ neutralising antibody detection kits for SARS-CoV-2 variants